A Chinese medicine composition for treating cardiovascular diseases, preparation method and application

By using traditional Chinese medicine compositions such as Astragalus, peach kernel, Trichosanthes kirilowii, rhubarb and celery, through water extraction and enzymatic extraction methods, the problems of excessive Chinese medicine flavor and limited hemoritic improvement effects in the prior art were solved, and significant results were achieved blood lipid regulation and cardiovascular disease treatment effect.

CN118767063BActive Publication Date: 2024-11-22GUANGZHOU BOJI MEDICINE SERVICES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411261940.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-10
Publication Date
2024-11-22
Estimated Expiration
2044-09-10

AI Technical Summary

Technical Problem

The prior art has made it difficult to study basic substances in the treatment of cardiovascular diseases, and its effect is limited in improving fundamental factors such as hematologic rheology, making it difficult to control disease onset for a long time.

Method used

A Chinese medicine composition, including astragalus, peach kernel, trichosanthes kirilowii, rhubarb, sauerkra and cabbage, was prepared by water extraction and enzymatic extraction, combined with ethanol reflux extraction and enzymatic removal, to form a Chinese medicine extract with significant synergistic effect. , used to treat cardiovascular diseases.

Benefits of technology

It significantly reduces total cholesterol, low-density lipoprotein and triglycerides in the blood, improves high-density lipoprotein content, improves blood rheology, and has good therapeutic effects on regulating blood lipids and cardiovascular diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
Patent Text Reader

Abstract

The present invention belongs to the technical field of traditional Chinese medicine, and specifically relates to a Chinese medicine composition for treating cardiovascular diseases and a preparation method thereof. The Chinese medicine composition comprises astragalus, notoginseng, salvia miltiorrhiza, peach kernel, trichosanthes, rhubarb, smilax glabra and radix glabra. The preparation method comprises first extracting astragalus, notoginseng, salvia miltiorrhiza, peach kernel and smilax glabra to obtain an extract; then enzymolyzing trichosanthes, rhubarb and radix glabra to obtain an enzymolyzate; finally, mixing the extract and the enzymolyzate, concentrating and drying. The present invention uses an appropriate amount of smilax glabra and rhubarb in a prescription in combination with other medicinal ingredients, which has obvious synergistic effects, has obvious effects on regulating blood lipids and improving blood rheology, has significant therapeutic effects, is simple to combine, and provides a new solution for the treatment of patients with cardiovascular diseases, and has practical application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition for treating cardiovascular diseases, a preparation method and an application thereof. Background Art

[0002] Cardiovascular disease, also known as circulatory system disease, refers to a range of disorders of the circulatory system. The circulatory system refers to the organs and tissues that transport blood in the human body, primarily including the heart and blood vessels (arteries, veins, and capillaries). These disorders are generally associated with atherosclerosis. The most common cardiovascular diseases include arrhythmias, myocardial ischemia, angina pectoris, and myocardial infarction. Cardiovascular disease is often multifactorial. Currently, to control cardiovascular disease, patients must take various anti-cardiovascular medications. Because medications can only control the disease to a certain extent, treatment can only be sustained long-term. Once the medication loses its effect or is discontinued, cardiovascular disease may recur. They can only alleviate symptoms but cannot address the underlying problem. For example, lipid-lowering drugs can normalize blood lipids, but blood clots in blood vessels will not be eliminated simply by normalizing blood lipids.

[0003] The efficacy of drugs for cardiovascular diseases is limited. Long-term use of the drugs can cause side effects such as liver and kidney damage or even failure. There are few drugs that can control the onset of cardiovascular diseases in the long term.

[0004] Traditional Chinese Medicine (TCM) emphasizes a holistic approach and dialectical treatment, emphasizing multi-pathway, comprehensive, holistic regulation. Therefore, TCM demonstrates its unique advantages in treating cardiovascular disease. In recent years, research has demonstrated the efficacy and safety of TCM in treating cardiovascular disease, with significant progress achieved in both clinical trials and experimental research.

[0005] Chinese invention patent application CN1336221A discloses a traditional Chinese medicine for treating cardiovascular disease. The medicine comprises 100g of red ginseng, 100g of Panax notoginseng powder, 20g of processed aconite root, 20g of raw dragon bone, 30g of red peony root, 30g of angelica root, 60g of astragalus root, 15g of dried ginger, 30g of inulin flower, 30g of pollen cattail, 20g of schisandra chinensis, 20g of peach kernel, 30g of safflower, 30g of trichosanthes root, 15g of agarwood, and 20g of raw oyster, which are ground into powder, mixed evenly, sterilized, and then packaged into capsules. The finished product has the advantages of rapid effect, high cure rate, simple manufacturing process, low cost, no toxic side effects, and safe administration.

[0006] Chinese invention patent application CN108653548A discloses a traditional Chinese medicine for treating cardiovascular diseases, comprising 10 parts of mistletoe, 5 parts of motherwort, 7 parts of gentian, 3 parts of rhizoma anemarrhenae, 8 parts of millettia reticulata, 6 parts of liquorice, 7 parts of herba schizonepetae, and 5 parts of ginseng. In view of the above technical solution, the present invention can maintain a healthy cardiovascular system, improve cardiovascular function, and effectively reduce the probability of cardiovascular disease by taking the medicine once a day for a period of one month for more than half a year.

[0007] Chinese invention patent application CN116920062A discloses a traditional Chinese medicine composition for treating cardiovascular diseases, relating to the technical field of traditional Chinese medicine. The composition comprises: 3-10 grams of Corydalis yanhusuo, 1.5-3 grams of leech, 10-15 grams of Salvia miltiorrhiza, 3-10 grams of Chuanxiong, 5-10 grams of Sophora japonica, 6-15 grams of Red Peony Root, 10-15 grams of Astragalus membranaceus, 5-12 grams of Achyranthes bidentata, 3-6 grams of safflower, 5-10 grams of peach kernel, 5-10 grams of Alisma orientalis, 3-10 grams of Lotus Root, 9-15 grams of Polygonum cuspidatum, 3-10 grams of Curcuma longa, 3-10 grams of Chicken's Gizzard Stone, and 10-15 grams of Ganoderma lucidum. The composition prepared by the invention is prepared from pure traditional Chinese medicine, has relatively small side effects, a short treatment cycle, is not prone to recurrence, and has a certain preventive effect on cardiovascular diseases.

[0008] In summary, existing technologies have explored traditional Chinese medicine methods for treating cardiovascular diseases and achieved some success. However, some have multiple medicinal flavors, which complicates research on the underlying substance of their efficacy and hinders their promotion. Others, while more refined, still require further improvement in fundamental factors such as improving hemorheology. Summary of the Invention

[0009] In view of the deficiencies in the prior art, the present invention provides a composition for treating cardiovascular diseases.

[0010] Terms and Claims of the Present Invention:

[0011] 1. As used herein, the articles "a", "an" and "the" include plural referents unless expressly limited to one or more referents otherwise.

[0012] 2. As used herein, numerical ranges: Unless expressly stated otherwise, all ranges or ratios disclosed herein are to be understood to include any and all subranges or subratios contained therein. For example, a range or ratio stated as 1 to 30 is to be considered inclusive of any and all subranges or subratios, integers, decimals, or subranges or subratios comprised therein, including the minimum value of 1 and the maximum value of 30.

[0013] 3. As used herein, the terms "comprises," "includes," "have," "has," "may," "contain" and their variations are open-ended conjunctions or terms that do not exclude the possibility of additional compositions or structures.

[0014] In order to achieve the purpose of the present invention, the technical solutions adopted are as follows:

[0015] A traditional Chinese medicine composition for treating cardiovascular diseases comprises astragalus, peach kernel, trichosanthes root, rhubarb, smilax china and ginkgo biloba.

[0016] The medicinal properties and effects of each drug in the present invention are as follows:

[0017] Astragalus, which can be Astragalus membranaceus or Astragalus mongholicus, has a sweet and slightly warm taste and can invigorate Qi and raise Yang. Flowing Qi promotes blood circulation, which in turn alleviates blood stasis. Modern research indicates that Astragalus can disaggregate aggregated platelets, inhibit platelet phosphodiesterase activity, and increase platelet cyclic adenosine monophosphate (cAMP) levels, thereby inhibiting platelet aggregation.

[0018] Panax notoginseng is a perennial, upright herbaceous plant of the genus Panax, in the Araliaceae family. Its properties are sweet, slightly bitter, and warm. Its meridians are the Liver and Stomach meridians. It has the effects of dispersing blood stasis, stopping bleeding, and relieving swelling and pain. Modern research has shown that Panax notoginseng can effectively regulate blood lipids and prevent and treat cardiovascular diseases.

[0019] Salvia miltiorrhiza (Danshen) is a perennial herbaceous plant of the genus Salvia in the family Lamiaceae. It is slightly cold in nature and bitter in taste, entering the heart, pericardium, and liver meridians. It circulates through the bloodstream, promoting blood circulation. It has the effects of promoting blood circulation, removing blood stasis, relieving pain through menstruation, clearing the heart and relieving restlessness, and cooling the blood and eliminating carbuncles.

[0020] Peach kernels are the dried mature seeds of Prunus persica (L.) Batsch or Prunus davidiana (Carr.) Franch., both in the Rosaceae family. The fruits are harvested when ripe, the pulp and shell removed, the seeds removed, and sun-dried. They have a bitter, sweet, and neutral flavor. They enter the Heart, Liver, and Large Intestine meridians. They promote blood circulation, dissipate blood stasis, moisten the intestines and promote bowel movements, relieve coughs and asthma. They are used to treat amenorrhea, dysmenorrhea, lumps and abdominal masses, injuries from falls, and constipation caused by dry intestines.

[0021] Trichosanthes kirilowii is bitter and cold in nature, and has antipyretic, thirst-quenching, diuretic, antitussive and expectorant effects. Modern research shows that Trichosanthes kirilowii has the effects of dilating coronary arteries, resisting myocardial ischemia, improving microcirculation, inhibiting platelet aggregation, resisting hypoxia, and resisting arrhythmia. It also has anti-ulcer and laxative effects on the digestive system.

[0022] Rhubarb is the dried root and rhizome of Rheum palmatum L., Rheum tanguticum, and Rheum officinale, all members of the Polygonaceae family. The Shennong's Herbal Classic states that rhubarb has the effects of "clearing blood stasis, treating blood stasis, cold and heat, dissolving lumps and accumulations, removing retained fluid and food, cleansing the intestines and stomach, promoting the flow of fluids and food, regulating digestion, and calming the five internal organs." Modern research indicates that rhubarb and its active ingredients can directly or indirectly protect against myocardial ischemia through anti-thrombotic and anti-coronary artery spasm effects, and can also prevent atherosclerosis by inhibiting the proliferation of vascular smooth muscle cells.

[0023] Smilax china L., first recorded in Ming Yi Bie Lu, is a new species in the 2005 edition of the Chinese Pharmacopoeia. Its medicinal part is the dried rhizome of the lily family plant Smilax china L., which has the effects of dispelling wind and dampness, detoxifying and relieving blood stasis.

[0024] Glehnia littoralis, a plant of the genus Panax notoginseng in the Asteraceae family, is also known as white-backed Panax notoginseng, rich vegetable, hypoglycemic grass, and divine grass. Approved as a new resource food in 2010, Glehnia littoralis is cultivated on a large scale in Guangxi, Fujian, and Shanxi provinces of my country. It boasts laxative properties, clears heat and cools the blood, and regulates the immune system. Modern research indicates that Glehnia littoralis significantly reduces the three highs.

[0025] Furthermore, the Chinese medicine composition comprises, by weight, 5-10 parts of Astragalus, 5-10 parts of Panax notoginseng, 5-10 parts of Salvia miltiorrhiza, 5-10 parts of peach kernel, 5-10 parts of Trichosanthes, 1-5 parts of Rhubarb, 1-5 parts of Smilax china and 1-5 parts of Ginkgo biloba.

[0026] Furthermore, the Chinese medicine composition comprises 5 parts of Astragalus, 5 parts of Panax notoginseng, 5 parts of Salvia miltiorrhiza, 5 parts of peach kernel, 5 parts of Trichosanthes kirilowii, 1 part of Rhubarb, 1 part of Smilax china and 1 part of Ginkgo biloba;

[0027] The second object of the present invention is to provide a method for preparing the above-mentioned Chinese medicine composition, comprising the following steps:

[0028] (1) Extracting Astragalus, Panax notoginseng, Salvia miltiorrhiza, peach kernel and Smilax china to obtain an extract;

[0029] (2) Enzymatically hydrolyzing Trichosanthes kirilowii, Rhubarb and Ginkgo biloba to obtain an enzymatic hydrolyzate;

[0030] (3) Mix the extract and the enzymatic hydrolysate, concentrate and dry them.

[0031] Furthermore, the extraction in step (1) is performed by first extracting with water, filtering, and then extracting the residue with alcohol, and combining the two extraction solutions.

[0032] Furthermore, before the enzymolysis, 3-5 times the amount of water is added to the Trichosanthes kirilowii, rhubarb and Ganoderma lucidum, and the amount of the enzyme used is 1-3% of the mass of the water.

[0033] Furthermore, the water extraction temperature is 80-90°C and the time is 0.5-1h;

[0034] Furthermore, the amount of water is 3-5 times the total mass of Astragalus, Panax notoginseng, Salvia miltiorrhiza, Peach Kernel and Smilax china;

[0035] Furthermore, the alcohol extraction adopts heating reflux extraction with a volume fraction of 50-65% ethanol solution, and the extraction time is 0.5-2h.

[0036] Furthermore, the enzyme used in step (2) is a compound of xylanase and pectinase;

[0037] Furthermore, the mass ratio of xylanase to pectinase is 1:0.1-0.5.

[0038] Furthermore, the enzymatic hydrolysis temperature is 30-45° C., the enzymatic hydrolysis time is 1-2 h, and the enzymatic hydrolysis pH is 6-7.

[0039] Another object of the present invention is to provide the use of the above-mentioned traditional Chinese medicine composition in the preparation of drugs for treating cardiovascular diseases.

[0040] Furthermore, the dosage forms of the drug include tablets, capsules, powders and oral solutions.

[0041] Compared with the prior art, the present invention has the following beneficial effects:

[0042] (1) The present invention has a reasonable compatibility and mainly treats various diseases caused by blood stasis in the chest. The chest is the center of Qi, the gathering place of blood, and the boundary of the liver meridian. In the formula, Astragalus membranaceus replenishes Qi, Panax notoginseng and Salvia miltiorrhiza break up blood stasis and moisten dryness, which are the main drugs. Peach kernel, Rhubarb and Smilax china help the main drugs to activate blood circulation and remove blood stasis, and relieve pain, which are the assistant drugs. Ganoderma lucidum moistens the intestines and promotes bowel movements, clears heat and cools blood, and Trichosanthes kirilowii is a diuretic, antitussive and expectorant. The two herbs guide blood downward, which are the guiding drugs. When used together, they can activate blood circulation and remove blood stasis, and various blood stasis symptoms can be cured.

[0043] (2) The various medicinal ingredients of the present invention are organically compatible. Studies have shown that Smilax china and Rhubarb have obvious synergistic effects when combined with other medicinal ingredients in the prescription. They can significantly reduce the total cholesterol, low-density lipoprotein, and triglyceride in the body's blood, increase the content of high-density lipoprotein, and have a good lipid-regulating effect. At the same time, the composition of the present invention can also reduce blood viscosity and reduce hematocrit, and has potential application value in the treatment of cardiovascular diseases.

[0044] (3) The present invention further studied the preparation method of the formula and found the key quality attribute parameters of the extracted medicinal materials. The optimal preparation process was obtained as follows: first, Astragalus, Panax notoginseng, Salvia miltiorrhiza, Peach Kernel and Smilax china were extracted with solvent water, then refluxed with 50-65% ethanol, and then enzymatically extracted with Trichosanthes kirilowii, Rhubarb and Ginkgo biloba. The extract of the composition prepared by this method was effective in improving blood rheology. DETAILED DESCRIPTION

[0045] The present invention will be further described below in conjunction with specific embodiments. The raw materials in the following examples are all commercially available conventional raw materials.

[0046] The manufacturer of xylanase is Nanjing Songguan Biotechnology Co., Ltd., with an enzyme activity of 100,000 U / g;

[0047] The manufacturer of pectinase is Shandong Sukehan Bioengineering Co., Ltd., and the enzyme activity is 30,000 U / g.

[0048] The manufacturer of cellulase is Shandong Yuzhixing Biotechnology Co., Ltd., and the enzyme activity is 100,000 U / g.

[0049] Example 1

[0050] The Chinese medicine composition for treating cardiovascular and cerebrovascular diseases in this embodiment comprises the following raw materials: 5 parts of Astragalus, 5 parts of Panax notoginseng, 5 parts of Salvia miltiorrhiza, 5 parts of Peach Kernel, 5 parts of Trichosanthes, 1 part of Rhubarb, 1 part of Smilax china and 1 part of Ginkgo biloba.

[0051] The parts are all by weight.

[0052] The preparation method is:

[0053] (1) Soak Astragalus, Panax notoginseng, Salvia miltiorrhiza, Peach Kernel and Smilax china in 3 times the amount of water for 30 minutes, then extract at 85℃ for 1 hour, filter to obtain the extract and the residue, then add 5 times the amount of 60% ethanol by volume and heat under reflux for 30 minutes, filter, and combine the extracted liquids to obtain the extract;

[0054] (2) Add 5 times the amount of water to Trichosanthes kirilowii, Rhubarb and Ganoderma lucidum, and then add a mixture of xylanase and pectinase with a mass ratio of 1:0.5 and 1% of the mass of water. Perform enzymolysis at 30°C and pH 6 for 1 hour, boil for 1 minute to inactivate the enzyme, and filter to obtain the enzymatic solution.

[0055] (3) Combine the extract and the enzymatic hydrolysate, reduce the pressure, concentrate to a relative density of 1.10, and vacuum dry.

[0056] Example 2

[0057] The Chinese medicine composition for treating cardiovascular and cerebrovascular diseases in this embodiment comprises the following raw materials: 10 parts of Astragalus, 10 parts of Panax notoginseng, 10 parts of Salvia miltiorrhiza, 10 parts of peach kernel, 10 parts of Trichosanthes kirilowii, 5 parts of Rhubarb, 5 parts of Smilax china and 5 parts of Ginkgo biloba.

[0058] The parts are all by weight.

[0059] The preparation method is:

[0060] (1) Soak Astragalus, Panax notoginseng, Salvia miltiorrhiza, Peach Kernel and Smilax china in 5 times the amount of water for 30 minutes, then extract at 90℃ for 0.5 hours, filter to obtain the extract and the residue, then add 65% ethanol (5 times the mass of the residue) and heat under reflux for 1 hour, filter, and combine the extracted liquid to obtain the extract;

[0061] (2) Add 5 times the amount of water to Trichosanthes kirilowii, rhubarb and white cabbage, and then add a mixture of xylanase and pectinase with a mass ratio of 1:0.1 and 3% of the mass of water. Hydrolyze at 45°C and pH 7 for 2 hours, boil for 1 minute to inactivate the enzyme, and filter to obtain the enzymatic solution;

[0062] (3) Combine the extract and the enzymatic hydrolysate, reduce the pressure, concentrate to a relative density of 1.15, and vacuum dry.

[0063] Example 3

[0064] The Chinese medicine composition for treating cardiovascular and cerebrovascular diseases in this embodiment comprises the following raw materials: 6 parts of Astragalus, 6 parts of Panax notoginseng, 6 parts of Salvia miltiorrhiza, 6 parts of Peach Kernel, 6 parts of Trichosanthes, 2 parts of Rhubarb, 2 parts of Smilax china and 2 parts of Ginkgo biloba.

[0065] The parts are all by weight.

[0066] The preparation method is:

[0067] (1) Soak Astragalus, Panax notoginseng, Salvia miltiorrhiza, Peach Kernel and Smilax china in 5 times the amount of water for 30 minutes, then extract at 80℃ for 1 hour, filter to obtain the extract and the residue, then add 50% ethanol (5 times the mass of the residue) and heat under reflux for 2 hours, filter, and combine the extracted liquids to obtain the extract;

[0068] (2) Add 5 times the amount of water to Trichosanthes kirilowii, rhubarb and white cabbage, and then add a mixture of xylanase and pectinase with a mass ratio of 1:0.3 and 2% of the water mass. Perform enzymolysis at 35°C and pH 6.5 for 1 hour, boil for 1 minute to inactivate the enzyme, and filter to obtain the enzymatic solution;

[0069] (3) Combine the extract and the enzymatic hydrolysate, reduce the pressure, concentrate to a relative density of 1.15, and vacuum dry.

[0070] The following comparative examples 1-3 are individual prescriptions screened in the early stages of the experiment:

[0071] Comparative Example 1

[0072] The Chinese medicine composition for treating cardiovascular and cerebrovascular diseases in this comparative example comprises the following raw materials: 5 parts of Astragalus, 5 parts of Panax notoginseng, 5 parts of Salvia miltiorrhiza, 5 parts of Peach Kernel, 5 parts of Trichosanthes, 2 parts of Smilax china and 1 part of Ginkgo biloba.

[0073] The parts are all by weight.

[0074] The preparation method is:

[0075] (1) Soak Astragalus, Panax notoginseng, Salvia miltiorrhiza, Peach Kernel and Smilax china in 3 times the amount of water for 30 minutes, then extract at 85℃ for 1 hour, filter to obtain the extract and the residue, then add 5 times the amount of 60% ethanol by volume and heat under reflux for 30 minutes, filter, and combine the extracted liquids to obtain the extract;

[0076] (2) Add 5 times the amount of water to Trichosanthes kirilowii and Ganoderma lucidum, and then add a mixture of xylanase and pectinase with a mass ratio of 1:0.5 and 1% of the mass of water. Hydrolyze at 30°C and pH 6 for 1 hour, boil for 1 minute to inactivate the enzyme, and filter to obtain the enzymatic solution.

[0077] (3) Combine the extract and the enzymatic hydrolysate, reduce the pressure, concentrate to a relative density of 1.10, and vacuum dry.

[0078] Comparative Example 2

[0079] The Chinese medicine composition for treating cardiovascular and cerebrovascular diseases in this comparative example comprises the following raw materials: 5 parts of astragalus, 5 parts of notoginseng, 5 parts of salvia miltiorrhiza, 5 parts of peach kernel, 5 parts of trichosanthes, 2 parts of rhubarb and 1 part of white cabbage.

[0080] The parts are all by weight.

[0081] The preparation method is:

[0082] (1) Soak Astragalus, Panax notoginseng, Salvia miltiorrhiza, and peach kernel in 3 times the amount of water for 30 minutes, then extract at 85°C for 1 hour, filter, and obtain the extract and the residue. Then add 5 times the amount of 60% ethanol by volume and heat under reflux for 30 minutes, filter, and combine the extracted liquids to obtain the extract;

[0083] (2) Add 5 times the amount of water to Trichosanthes kirilowii, Rhubarb and Ganoderma lucidum, and then add a mixture of xylanase and pectinase with a mass ratio of 1:0.5 and 1% of the mass of water. Perform enzymolysis at 30°C and pH 6 for 1 hour, boil for 1 minute to inactivate the enzyme, and filter to obtain the enzymatic solution.

[0084] (3) Combine the extract and the enzymatic hydrolysate, reduce the pressure, concentrate to a relative density of 1.10, and vacuum dry.

[0085] Comparative Example 3

[0086] The Chinese medicine composition for treating cardiovascular and cerebrovascular diseases in this example comprises the following raw materials: 5 parts of Astragalus, 5 parts of Panax notoginseng, 5 parts of Salvia miltiorrhiza, 5 parts of Peach Kernel, 5 parts of Trichosanthes, 1 part of Rhubarb, 1 part of Smilax china and 1 part of Ginkgo biloba.

[0087] The parts are all by weight.

[0088] The preparation method is:

[0089] (1) Soak Astragalus, Panax notoginseng, Salvia miltiorrhiza, Peach Kernel and Smilax china in 3 times the amount of water for 30 minutes, then heat and reflux for extraction for 1 hour (just allow it to reflux), filter to obtain the extract and the residue, then add 5 times the amount of 60% ethanol by volume and heat and reflux for extraction for 30 minutes, filter, and combine the extracted liquids to obtain the extract;

[0090] (2) Add 5 times the amount of water to Trichosanthes kirilowii, Rhubarb and Ganoderma lucidum, and then add a mixture of cellulase and pectinase with a mass ratio of 1:0.5 and 1% of the mass of water. Perform enzymolysis at 30°C and pH 6 for 1 hour, boil for 1 minute to inactivate the enzyme, and filter to obtain the enzymatic solution.

[0091] (3) Combine the extract and the enzymatic hydrolysate, reduce the pressure, concentrate to a relative density of 1.10, and vacuum dry.

[0092] Effects of drug efficacy experiments on hemorheology in model rats

[0093] Experimental animals: Sprague-Dawley rats, SPF grade, weighing 223.3-244.9 g, aged 6-7 weeks, half male and half female. Provided by Hunan Slake Jingda Laboratory Animal Co., Ltd., Laboratory Animal Quality Certificate No.: 430727201101012371, Laboratory Animal Production License No.: SCXK (Xiang) 2019-0004. Housing conditions: temperature 20-26°C, humidity 40-70%, 12h / 12h light / dark cycle, free access to food and water. Experiments were conducted after the rats had been acclimated to the feeding for one week.

[0094] High-fat formula: Disperse edible oil with hot water to a concentration of 18%, then add 10% cholesterol, 0.2% propylthiouracil, 5% sodium cholate, and 50% Tween-80 by weight of water, stir, and add hot water to 100 mL and stir evenly.

[0095] Establishment of animal model

[0096] SD rats (weighing 200±20 g) were fed ad libitum for 1 week and randomly divided into 9 groups, half male and half female, with 8 rats in each group, namely the normal group, the model group, the positive group, the Example 1-3 groups, and the comparative example 1-3 groups. The rats in each group were fed ad libitum. Except for the rats in the normal group, the rats in each group were fed a high-fat formula every morning for 3 weeks.

[0097] Trial administration

[0098] The positive group was administered simvastatin suspension 1.5 mg / kg;

[0099] The groups of Examples 1-3 and Comparative Examples 1-3 were given the compositions prepared by the corresponding groups, which were dissolved and dispersed in warm water at a dosage of 5 g of crude drug / kg;

[0100] The normal group was given the same dose of normal saline;

[0101] Three weeks after oral administration, rats were fasted for 12 hours, and blood was collected from the fundus venous plexus. Plasma was separated, and levels of total cholesterol, triglycerides, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) were measured using ELISA. Whole blood high-shear viscosity (nH), whole blood low-shear viscosity (nL), plasma viscosity (np), and hematocrit (HCT) were measured using an automatic hemorheology instrument. The results are shown in Tables 1-2.

[0102] Table 1

[0103]

[0104] Note: Compared with the normal control group, * P<0.01; compared with the model group, # P<0.05, ## P<0.01; compared with the Example 1 group, △ P<0.05.

[0105] Results and Discussion: After modeling, the blood lipid levels of rats increased significantly, and there was a significant difference compared with the normal group ( * P < 0.01);

[0106] After the model was established and the drug was administered for 3 weeks, both the Example 1-3 and the Comparative Example 1-3 groups were able to improve the blood lipid levels of the rats to a certain extent. There was a significant difference between the Example 1-3 group and the model control group ( # P < 0.05), which is equivalent to the therapeutic effect of the positive group; Comparative Examples 1-2 use a prescription with missing components, and Comparative Example 3 uses other preparation methods. The Chinese medicine composition finally prepared has a poorer improvement on the total cholesterol, triglyceride, and low-density lipoprotein blood lipid indicators of rats than the embodiment group, and the results are statistically significant ( △ P<0.05).

[0107] Table 2

[0108]

[0109] Note: Compared with the normal control group, * P<0.01; compared with the model group, # P<0.05, ## P<0.01; compared with the Example 1 group, △ P<0.05.

[0110] Results and Discussion: After modeling, the blood rheology of rats increased significantly, and there was a significant difference compared with the normal group ( * P < 0.01);

[0111] After 3 weeks of treatment, the whole blood high shear viscosity (nH), whole blood low shear viscosity (nL), plasma viscosity (np), and hematocrit (HCT) of the Example 1-3 group and the Comparative Example 1-3 group were all reduced to a certain extent, and there was a significant difference between the Example 1-3 group and the model control group ( # P<0.05, ## P<0.01).

[0112] In addition, the comparative examples 1-2 used a formula lacking in flavor, and the comparative example 3 used an inappropriate preparation method. The extracts of the Chinese medicine composition finally prepared were less effective in improving the blood rheology indexes than those of the present invention examples 1-3, and the results were statistically significant ( △ P<0.05).

[0113] The compositions of Examples 1-3 of the present invention can significantly reduce total cholesterol, low-density lipoprotein, and triglycerides in the body's blood, increase the content of high-density lipoprotein, and have a good lipid-regulating effect. At the same time, they can also reduce plasma viscosity and hematocrit, and have a good therapeutic effect on cardiovascular diseases.

[0114] The above detailed description is a specific description of one feasible embodiment of the present invention. This embodiment is not intended to limit the patent scope of the present invention. Any equivalent implementation or modification that does not depart from the present invention should be included in the scope of the technical solution of the present invention.

Claims

1. A Chinese medicine composition for treating cardiovascular diseases, characterized in that: The raw materials of the Chinese medicine composition are 5-10 parts of astragalus, 5-10 parts of notoginseng, 5-10 parts of salvia miltiorrhiza, 5-10 parts of peach kernel, 5-10 parts of trichosanthes, 1-5 parts of rhubarb, 1-5 parts of smilax china and 1-5 parts of white cabbage by weight; The preparation method of the Chinese medicine composition comprises the following steps: (1) extracting astragalus, notoginseng, salvia miltiorrhiza, peach kernel and smilax china to obtain an extract; (2) hydrolyzing the Trichosanthes kirilowii, Rhubarb and Glehnia littoralis to obtain an enzymatic hydrolyzate; (3) Mix the extract and the enzymatic hydrolysate, concentrate and dry them; The extraction in step (1) is to first extract with water, filter, then extract with alcohol, and combine the two extraction solutions; the temperature of the water extraction is 80-90°C, and the time is 0.5-1h; The enzyme used in step (2) is a compound of xylanase and pectinase.

2. The Chinese medicine composition according to claim 1, characterized in that: The Chinese medicine composition comprises 5 parts of astragalus, 5 parts of panax notoginseng, 5 parts of salvia miltiorrhiza, 5 parts of peach kernel, 5 parts of trichosanthes, 1 part of rhubarb, 1 part of smilax china and 1 part of ginkgo biloba.

3. A method for preparing the Chinese medicine composition according to any one of claims 1 to 2, characterized in that: The steps include: (1) extracting astragalus, notoginseng, salvia miltiorrhiza, peach kernel and smilax china to obtain an extract; (2) hydrolyzing the Trichosanthes kirilowii, Rhubarb and Glehnia littoralis to obtain an enzymatic hydrolyzate; (3) Mix the extract and the enzymatic hydrolysate, concentrate and dry them; The extraction in step (1) is to first extract with water, filter, then extract with alcohol on the residue, and combine the two extraction solutions; the temperature of the water extraction is 80-90°C, and the time is 0.5-1h.

4. The preparation method according to claim 3, characterized in that: The amount of water used in step (1) is 3-5 times the total mass of astragalus, notoginseng, salvia miltiorrhiza, peach kernel and smilax china. The alcohol extraction adopts heating reflux extraction with a volume fraction of 50-65% ethanol solution, and the extraction time is 0.5-2h.

5. The preparation method according to claim 3, characterized in that: In step (2), the mass ratio of xylanase to pectinase is 1:0.1-0.5; before the enzymolysis, 3-5 times the amount of water is added to the Trichosanthes kirilowii, rhubarb and Glehnia littoralis, and the amount of the enzyme used is 1-3% of the mass of the water.

6. The preparation method according to claim 3, characterized in that: The temperature of the enzymolysis is 30-45° C., the time of the enzymolysis is 1-2 hours, and the pH of the enzymolysis is 6-7.

7. Use of the Chinese medicine composition according to any one of claims 1 to 2 in the preparation of drugs for treating cardiovascular diseases.

8. The use according to claim 7, characterized in that: The dosage forms of the drug include tablets, capsules, powders and oral solutions.